Search results
Cryoablation: Purpose and what to expect
Medical News Today· 1 day agoCryoablation involves applying extremely cold gas or liquid to an area of cancerous or abnormal tissue. The treatment freezes and destroys the cells....
Germany’s ITM raises $205M as radiopharma field booms
BioPharma Dive via Yahoo Finance· 21 hours agoSteffen Schuster, the longtime CEO of ITM, hasn’t been surprised by the frenzy of activity. He’s...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 2 days agoFPI-2265 is a promising new treatment for patients with metastatic castration-resistant prostate ...
Theralase(R) Successfully Destroys Lung Cancer
Digital Journal· 18 hours ago("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and/or radiation
Nucleus RadioPharma secures Series A investment from AstraZeneca
BioPharma-Reporter· 19 hours agoThe investment from AstraZeneca marks a strategic move to further expand Nucleus's capabilities in developing targeted radiotherapies and theranostics, aimed at making cancer
Cancer care’s surprising source of greenhouse gasses
The San Francisco Examiner· 3 days agoThe biggest source of emissions in hospitals and clinics providing radiation treatment for cancer are the systems used to operate buildings ...
Exploring the potential of dietary phytochemicals in cancer prevention
Medical Xpress· 6 days agoCancer remains a significant global health challenge and is a leading cause of mortality worldwide....
Cheap Drug Eases Hot Flashes in Men With Prostate Cancer
MedPage Today· 4 days agoA widely available anticholinergic significantly improved hot flash symptoms in men taking androgen...
“Monstrous” Discovery: Scientists Identify Key to Stopping Cancer Recurrence
SciTechDaily· 3 days agoScientists have discovered that polyploid giant cancer cells, which are monstrously oversized and...
Sarcoma immunotherapy clinical trial reduces risk of relapse by 43%
Medical Xpress· 2 days agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare ...
